Literature DB >> 24849666

Low-level laser therapy effectively prevents secondary brain injury induced by immediate early responsive gene X-1 deficiency.

Qi Zhang1, Chang Zhou1, Michael R Hamblin2, Mei X Wu2.   

Abstract

A mild insult to the brain can sometimes trigger secondary brain injury, causing severe postconcussion syndrome, but the underlying mechanism is ill understood. We show here that secondary brain injury occurs consistently in mice lacking immediate early responsive gene X-1 (IEX-1), after a gentle impact to the head, which closely simulates mild traumatic brain injury in humans. The pathologic lesion was characterized by extensive cell death, widespread leukocyte infiltrates, and severe tissue loss. On the contrary, a similar insult did not induce any secondary injury in wild-type mice. Strikingly, noninvasive exposure of the injured head to a low-level laser at 4 hours after injury almost completely prevented the secondary brain injury in IEX-1 knockout mice. The low-level laser therapy (LLLT) suppressed proinflammatory cytokine expression like interleukin (IL)-1β and IL-6 but upregulated TNF-α. Moreover, although lack of IEX-1 compromised ATP synthesis, LLLT elevated its production in injured brain. The protective effect of LLLT may be ascribed to enhanced ATP production and selective modulation of proinflammatory mediators. This new closed head injury model provides an excellent tool to investigate the pathogenesis of secondary brain injury as well as the mechanism underlying the beneficial effect of LLLT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24849666      PMCID: PMC4126101          DOI: 10.1038/jcbfm.2014.95

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths.

Authors:  Qiuhe Wu; Weijun Xuan; Takahiro Ando; Tao Xu; Liyi Huang; Ying-Ying Huang; Tianghong Dai; Saphala Dhital; Sulbha K Sharma; Michael J Whalen; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2012-01-24       Impact factor: 4.025

2.  Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.

Authors:  Lee E Goldstein; Andrew M Fisher; Chad A Tagge; Xiao-Lei Zhang; Libor Velisek; John A Sullivan; Chirag Upreti; Jonathan M Kracht; Maria Ericsson; Mark W Wojnarowicz; Cezar J Goletiani; Giorgi M Maglakelidze; Noel Casey; Juliet A Moncaster; Olga Minaeva; Robert D Moir; Christopher J Nowinski; Robert A Stern; Robert C Cantu; James Geiling; Jan K Blusztajn; Benjamin L Wolozin; Tsuneya Ikezu; Thor D Stein; Andrew E Budson; Neil W Kowall; David Chargin; Andre Sharon; Sudad Saman; Garth F Hall; William C Moss; Robin O Cleveland; Rudolph E Tanzi; Patric K Stanton; Ann C McKee
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

3.  Specific helium-neon laser sensitivity of the purified cytochrome c oxidase.

Authors:  D Pastore; M Greco; S Passarella
Journal:  Int J Radiat Biol       Date:  2000-06       Impact factor: 2.694

4.  Surveillance for traumatic brain injury-related deaths--United States, 1997-2007.

Authors:  Victor G Coronado; Likang Xu; Sridhar V Basavaraju; Lisa C McGuire; Marlena M Wald; Mark D Faul; Bernardo R Guzman; John D Hemphill
Journal:  MMWR Surveill Summ       Date:  2011-05-06

5.  Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion.

Authors:  Lívia Assis; Ana I S Moretti; Thalita B Abrahão; Vivian Cury; Heraldo P Souza; Michael R Hamblin; Nivaldo A Parizotto
Journal:  Lasers Surg Med       Date:  2012-09-21       Impact factor: 4.025

6.  Enhanced Th17 differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen species-mediated signaling.

Authors:  Liang Zhi; Irina V Ustyugova; Xinyuan Chen; Qi Zhang; Mei X Wu
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

7.  Comparison of therapeutic effects between pulsed and continuous wave 810-nm wavelength laser irradiation for traumatic brain injury in mice.

Authors:  Takahiro Ando; Weijun Xuan; Tao Xu; Tianhong Dai; Sulbha K Sharma; Gitika B Kharkwal; Ying-Ying Huang; Qiuhe Wu; Michael J Whalen; Shunichi Sato; Minoru Obara; Michael R Hamblin
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

8.  Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts.

Authors:  Aaron C-H Chen; Praveen R Arany; Ying-Ying Huang; Elizabeth M Tomkinson; Sulbha K Sharma; Gitika B Kharkwal; Taimur Saleem; David Mooney; Fiona E Yull; Timothy S Blackwell; Michael R Hamblin
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

9.  Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury.

Authors:  Edwin B Yan; Sarah C Hellewell; Bo-Michael Bellander; Doreen A Agyapomaa; M Cristina Morganti-Kossmann
Journal:  J Neuroinflammation       Date:  2011-10-28       Impact factor: 8.322

10.  Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen.

Authors:  Weijun Xuan; Fatma Vatansever; Liyi Huang; Qiuhe Wu; Yi Xuan; Tianhong Dai; Takahiro Ando; Tao Xu; Ying-Ying Huang; Michael R Hamblin
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more
  29 in total

1.  Low-level light in combination with metabolic modulators for effective therapy of injured brain.

Authors:  Tingting Dong; Qi Zhang; Michael R Hamblin; Mei X Wu
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

2.  Transcranial Low-Level Laser (Light) Therapy for Brain Injury.

Authors:  Connor Thunshelle; Michael R Hamblin
Journal:  Photomed Laser Surg       Date:  2016-12       Impact factor: 2.796

Review 3.  Photobiomodulation for traumatic brain injury and stroke.

Authors:  Michael R Hamblin
Journal:  J Neurosci Res       Date:  2017-11-13       Impact factor: 4.164

4.  Transcranial near-infrared photobiomodulation attenuates memory impairment and hippocampal oxidative stress in sleep-deprived mice.

Authors:  Farzad Salehpour; Fereshteh Farajdokht; Marjan Erfani; Saeed Sadigh-Eteghad; Siamak Sandoghchian Shotorbani; Michael R Hamblin; Pouran Karimi; Seyed Hossein Rasta; Javad Mahmoudi
Journal:  Brain Res       Date:  2018-01-04       Impact factor: 3.252

Review 5.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

6.  Effect of transcranial near-infrared photobiomodulation on cognitive outcomes in D-galactose/AlCl3 induced brain aging in BALB/c mice.

Authors:  Leila Hosseini; Narmin Farazi; Marjan Erfani; Javad Mahmoudi; Morteza Akbari; Seyed Hojjat Hosseini; Saeed Sadigh-Eteghad
Journal:  Lasers Med Sci       Date:  2021-10-01       Impact factor: 3.161

7.  Near-Infrared Light Increases Functional Connectivity with a Non-thermal Mechanism.

Authors:  Grzegorz M Dmochowski; Ahmed Duke Shereen; Destiny Berisha; Jacek P Dmochowski
Journal:  Cereb Cortex Commun       Date:  2020-03-19

8.  Repeated transcranial low-level laser therapy for traumatic brain injury in mice: biphasic dose response and long-term treatment outcome.

Authors:  Weijun Xuan; Liyi Huang; Michael R Hamblin
Journal:  J Biophotonics       Date:  2016-03-15       Impact factor: 3.207

Review 9.  Current application and future directions of photobiomodulation in central nervous diseases.

Authors:  Muyue Yang; Zhen Yang; Pu Wang; Zhihui Sun
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

10.  532 nm Low-Power Laser Irradiation Facilitates the Migration of GABAergic Neural Stem/Progenitor Cells in Mouse Neocortex.

Authors:  Yumi Fukuzaki; Hyeryun Shin; Hideki D Kawai; Banri Yamanoha; Shinichi Kogure
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.